Advertisement
U.S. markets closed
  • S&P Futures

    5,304.25
    -4.00 (-0.08%)
     
  • Dow Futures

    40,140.00
    -36.00 (-0.09%)
     
  • Nasdaq Futures

    18,465.00
    -38.75 (-0.21%)
     
  • Russell 2000 Futures

    2,145.20
    +6.80 (+0.32%)
     
  • Crude Oil

    83.11
    -0.06 (-0.07%)
     
  • Gold

    2,254.80
    +16.40 (+0.73%)
     
  • Silver

    25.10
    +0.18 (+0.74%)
     
  • EUR/USD

    1.0790
    -0.0003 (-0.03%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • Vix

    13.01
    +0.23 (+1.80%)
     
  • dólar/libra

    1.2623
    +0.0001 (+0.01%)
     
  • USD/JPY

    151.4810
    +0.1090 (+0.07%)
     
  • Bitcoin USD

    70,743.70
    +957.27 (+1.37%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,404.21
    +236.14 (+0.59%)
     

Here's How Much a $1000 Investment in Intuitive Surgical, Inc. Made 10 Years Ago Would Be Worth Today

For most investors, how much a stock's price changes over time is important. Not only can it impact your investment portfolio, but it can also help you compare investment results across sectors and industries.

FOMO, or the fear of missing out, also plays a role in investing, particularly with tech giants and popular consumer-facing stocks.

What if you'd invested in Intuitive Surgical, Inc. (ISRG) ten years ago? It may not have been easy to hold on to ISRG for all that time, but if you did, how much would your investment be worth today?

Intuitive Surgical, Inc.'s Business In-Depth

With that in mind, let's take a look at Intuitive Surgical, Inc.'s main business drivers.

Headquartered Sunnyvale, CA, Intuitive Surgical Inc (ISRG) designs, manufactures and markets the da Vinci surgical system and related instruments and accessories, which is an advanced robot-assisted surgical system. The surgical system comprises a surgeon’s console, patient-side cart, 3-D vision system, da Vinci Skills Simulator and Firefly Fluorescence Imaging.

Intuitive Surgical’s robot-based da Vinci surgical system enables minimally-invasive surgery that reduces the trauma associated with open surgery. The da Vinci System is powered by robotic technology which has provided the company with a solid exposure to Mechatronics, Robotocs and Artificial Intelligence for healthcare. The system provides 3-D High Definition vision, which helps surgeons gain superior visual clarity of target tissue and anatomy.

It also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures.  Additionally, the company sells various accessories comprising sterile drapes for ensuring sterile field during surgery; and vision products that include replacement 3D stereo endoscopes, camera heads, light guides, and other items that facilitate use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies.

The company operates through three segments: Instruments and Accessories, Systems and Services.

2020 Results at a Glance

Intuitive Surgical’s 2020 revenues totaled $4.36 billion, down 2.7% from 2019.

The company’s Instruments & Accessories sales were $2.46 billion (56.3% of net revenues), Systems revenues were $1.18 billion (27%) and Services revenues grossed $723.8 million (16.6%).

Bottom Line

Anyone can invest, but building a successful investment portfolio takes a combination of a few things: research, patience, and a little bit of risk. So, if you had invested in Intuitive Surgical, Inc. a decade ago, you're probably feeling pretty good about your investment today.

According to our calculations, a $1000 investment made in July 2011 would be worth $7,351.05, or a gain of 635.10%, as of July 30, 2021, and this return excludes dividends but includes price increases.

In comparison, the S&P 500 gained 241.97% and the price of gold went up 8.14% over the same time frame.

Analysts are anticipating more upside for ISRG.

Intuitive Surgical ended the second quarter on a solid note, wherein both earnings and revenues surpassed the Zacks Consensus Estimate. The company’s revenue growth in the second quarter of 2021 reflected procedure growth and higher-than-expected system placements. Strong segmental performance was seen during the second quarter. Intuitive Surgical recorded uptick in da Vinci procedure volume in the second quarter. Expansion in both gross and operating margins bodes well. Per management, the quarter exhibited both the demand for superior quality minimally invasive procedures along with a return to surgeries that were deferred during the pandemic. Shares of the company outperformed the industry in a year’s time. Yet, stiff competition in the global MedTech space and rising costs continue to raise concern.

The stock is up 5.83% over the past four weeks, and no earnings estimate has gone lower in the past two months, compared to 6 higher, for fiscal 2021. The consensus estimate has moved up as well.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Intuitive Surgical, Inc. (ISRG) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.

Advertisement